Chitosan: some pharmaceutical and biological aspects ‐ an update
暂无分享,去创建一个
[1] C. S. Chen,et al. Antibacterial effects of N-sulfonated and N-sulfobenzoyl chitosan and application to oyster preservation. , 1998, Journal of food protection.
[2] T. Ohe. Antigenotoxic activities of chitin and chitosan as assayed by sister chromatid exchange. , 1996, The Science of the total environment.
[3] R. Tasker,et al. Pharmacokinetics of an injectable sustained-release formulation of morphine for use in dogs. , 1997, Journal of veterinary pharmacology and therapeutics.
[4] K. Deuchi,et al. Effect of the viscosity or deacetylation degree of chitosan on fecal fat excreted from rats fed on a high-fat diet. , 1995, Bioscience, biotechnology, and biochemistry.
[5] S. Davis,et al. In vitro evaluation of the mucoadhesive properties of chitosan microspheres , 1998 .
[6] C. Stone,et al. Healing at skin graft donor sites dressed with chitosan. , 2000, British journal of plastic surgery.
[7] H. Kaş,et al. Chitosan microspheres of diclofenac sodium, II: In vitro and in vivo evaluation. , 1995, Die Pharmazie.
[8] G. Tsai,et al. Antibacterial activity of shrimp chitosan against Escherichia coli. , 1999, Journal of food protection.
[9] V. Dodane,et al. Effect of chitosan on epithelial permeability and structure. , 1999, International journal of pharmaceutics.
[10] J. Lehoux,et al. Some effects of chitosan on liver function in the rat. , 1993, Endocrinology.
[11] K. Ingvarsdóttir,et al. Chitosan Matrix Tablets: The Influence of Excipients on Drug Release , 1995 .
[12] T. Fujita,et al. Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats. , 1999, Life sciences.
[13] S. Bolton,et al. INVESTIGATION OF PROLONGED DRUG RELEASE FROM MATRIX FORMULATIONS OF CHITOSAN , 1990 .
[14] W. Paul,et al. Chitosan, a drug carrier for the 21st century : a review , 2000 .
[15] T J Smith,et al. Chitosan‐membrane interactions and their probable role in chitosan‐mediated transfection , 1998, Biotechnology and applied biochemistry.
[16] K. E. Gabr,et al. Effect of interpolymer complex formation of chitosan with pectin or acacia on the release behaviour of chlorpromazine HCl , 1993 .
[17] A. Sezer,et al. Release characteristics of chitosan treated alginate beads: I. Sustained release of a macromolecular drug from chitosan treated alginate beads. , 1999, Journal of microencapsulation.
[18] Y. Murata,et al. Additive effect of chondroitin sulfate and chitosan on drug release from calcium-induced alginate gel beads , 1996 .
[19] E. C. Sung,et al. The effect of chitosan (poly-N-acetyl glucosamine) on lingual hemostasis in heparinized rabbits. , 1999, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[20] G. Macleod,et al. The potential use of mixed films of pectin, chitosan and HPMC for bimodal drug release. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[21] R. Ilango,et al. Dissolution studies on tablets of ibuprofen using chitosan. , 1999, Indian journal of experimental biology.
[22] G. Kind,et al. Chitosan: evaluation of a new hemostatic agent. , 1990, Current surgery.
[23] S. Lin,et al. The effects of thickness and hardness of the coating film on the drug release rate of theophylline granules coated with chitosan-sodium tripolyphosphate complex. , 1985, Chemical & pharmaceutical bulletin.
[24] T. Miller,et al. Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis. , 1998, Atherosclerosis.
[25] Y. Kikuchi,et al. Polyelectrolyte Complexes of Chitosan with Sodium Carboxymethyldextran , 1978 .
[26] L. Hall,et al. Some chemical and analytical aspects of polysaccharide modifications. III. Formation of branched-chain, soluble chitosan derivatives , 1984 .
[27] F. Smales,et al. In vitro assessment of bioadhesion for periodontal and buccal drug delivery. , 1995, Biomaterials.
[28] R. Qaqish,et al. Evaluation of the Factors Influencing Stomach‐specific Delivery of Antibacterial Agents for Helicobacter pylori Infection , 1999, The Journal of pharmacy and pharmacology.
[29] H. Junginger,et al. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[30] H. Saitǒ,et al. Interaction of indomethacin with low molecular weight chitosan, and improvements of some pharmaceutical properties of indomethacin by low molecular weight chitosans , 1991 .
[31] P Buri,et al. Chitosan: a unique polysaccharide for drug delivery. , 1998, Drug development and industrial pharmacy.
[32] J. Kreuter,et al. Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs , 1996 .
[33] F. Mi,et al. Sustained-release of oxytetracycline from chitosan microspheres prepared by interfacial acylation and spray hardening methods. , 1997, Journal of microencapsulation.
[34] M. Meshali,et al. A new approach to encapsulating nonsteroidal anti-inflammatory drugs. IV. Effect of cellulose derivatives with different functional groups on the bioavailability and gastric ulcerogenic activity of acidic as well as basic nonsteroidal anti-inflammatory drugs. , 1989, Journal of microencapsulation.
[35] C. P. Sharma,et al. Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. , 1997, Journal of biomedical materials research.
[36] M. Pasta,et al. Intestinal peptide and protein delivery: novel bioadhesive drug-carrier matrix shielding from enzymatic attack. , 1998, Journal of pharmaceutical sciences.
[37] R. Duncan,et al. Evaluation of the biological properties of soluble chitosan and chitosan microspheres , 1997 .
[38] W. Rainer,et al. Chitosan: a new hemostatic. , 1983, The Annals of thoracic surgery.
[39] G. Buckton,et al. Modelling mucoadhesion by use of surface energy terms obtained by the Lewis acid-Lewis base approach , 1995 .
[40] M A Bayomi,et al. Preparation of casein-chitosan microspheres containing diltiazem hydrochloride by an aqueous coacervation technique. , 1998, Pharmaceutica acta Helvetiae.
[41] T. Fujita,et al. Validation of a Pharmacokinetic Model of Colon‐specific Drug Delivery and the Therapeutic Effects of Chitosan Capsules Containing 5‐Aminosalicylic Acid on 2,4,6‐Trinitrobenzenesulphonic Acid‐induced Colitis in Rats , 1999, The Journal of pharmacy and pharmacology.
[42] H. Doorne,et al. Stability and in vitro activity of nystatin and its γ-cyclodextrin complex against Candida albicans , 1991 .
[43] Claus-Michael Lehr,et al. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers , 1992 .
[44] P. Perugini,et al. Different molecular weight chitosan microspheres: influence on drug loading and drug release. , 1998, Drug development and industrial pharmacy.
[45] J. Anderson,et al. A Comparison of the Lipid-Lowering and Intestinal Morphological Effects of Cholestyramine, Chitosan, and Oat Gum in Rats , 1988, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[46] Claus-Michael Lehr,et al. Bioadhesive polymers for the peroral delivery of peptide drugs , 1994 .
[47] K. Leong,et al. DNA-polycation nanospheres as non-viral gene delivery vehicles. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[48] S. Harding,et al. Hydrodynamic characterization of chitosans varying in degree of acetylation. , 1993, International journal of biological macromolecules.
[49] M. Wada,et al. Accelerating effect of chitosan intake on urinary calcium excretion by rats. , 1997, Bioscience, biotechnology, and biochemistry.
[50] V. Zecchi,et al. Controlled Insulin Release from Chitosan Microparticles , 1998, Archiv der Pharmazie.
[51] 김동만,et al. Rheological properties , 1992, Physics Subject Headings (PhySH).
[52] A. Bernkop‐Schnürch,et al. Chitosan‐EDTA Conjugate: A Novel Polymer for Topical Gels , 1998, The Journal of pharmacy and pharmacology.
[53] C. Yomota,et al. [Usage of chitosan as a pharmaceutical material effectiveness as an additional additives of sodium alginate]. , 1990, Eisei Shikenjo hokoku. Bulletin of National Institute of Hygienic Sciences.
[54] C. Yomota,et al. [Sustained-release effect of the direct compressed tablet based on chitosan and Na alginate]. , 1994, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.
[55] Tatsuaki Yamaguchi,et al. Effect of Chitosan on Renal Function in Patients with Chronic Renal Failure , 1997, The Journal of pharmacy and pharmacology.
[56] H Lennernäs,et al. Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[57] L-K Han,et al. Reduction in fat storage during chitin-chitosan treatment in mice fed a high-fat diet , 1999, International Journal of Obesity.
[58] J. Kristl,et al. Hydrocolloids and gels of chitosan as drug carriers , 1993 .
[59] T. Imai,et al. Enhancement of Dissolution Rates of Several Drugs by Low-Molecular Chitosan and Alginate , 1990 .
[60] María J. Alonso,et al. Development of a freeze-dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration , 1999 .
[61] A. Hoekstra,et al. Percutaneous microcrystalline chitosan application for sealing arterial puncture sites. , 1998, Biomaterials.
[62] C. Remuñán-López,et al. Effect of chitosan and chitosan glutamate enhancing the dissolution properties of the poorly water soluble drug nifedipine , 1998 .
[63] L. Lim,et al. Effect of magnesium stearate on chitosan microspheres prepared by an emulsification-coacervation technique. , 1998, Journal of Microencapsulation.
[64] A. Bernkop‐Schnürch,et al. Basic studies on bioadhesive delivery systems for peptide and protein drugs , 1998 .
[65] H. Yamahara,et al. Tableting of coated particles. I. Small particle size chitosan as an agent protecting coating membrane from mechanical damage of compression force. , 1997, Chemical and pharmaceutical bulletin.
[66] A. Perkins,et al. Evaluation of the clearance characteristics of bioadhesive systems in humans. , 1999, International journal of pharmaceutics.
[67] T. Nagai,et al. Characteristics of polyion complexes of chitosan with sodium alginate and sodium polyacrylate , 1990 .
[68] M. Alonso,et al. Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[69] T. Masada,et al. Effect of interpolymer complex formation on bioadhesive property and drug release phenomenon of compressed tablet consisting of chitosan and sodium hyaluronate. , 1990, Chemical & pharmaceutical bulletin.
[70] Pruthvipathy R. Katikaneni,et al. Chitosan as a tablet binder , 1992 .
[71] Y. Murata,et al. Preparation and drug retention of biodegradable chitosan gel beads. , 1999, Chemical & pharmaceutical bulletin.
[72] F. Otero-Espinar,et al. Chitosan and chondroitin microspheres for oral-administration controlled release of metoclopramide. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[73] L. Illum,et al. Chitosan and its use as a pharmaceutical excipient. , 1998, Pharmaceutical research.
[74] E. Wuolijoki,et al. Decrease in serum LDL cholesterol with microcrystalline chitosan. , 1999, Methods and findings in experimental and clinical pharmacology.
[75] L. Block,et al. Use of chitosan in compressed tablets of diclofenac sodium: inhibition of drug release in an acidic environment. , 1997, Pharmaceutical development and technology.
[76] S. Davis,et al. Chitosan microspheres prepared by spray drying. , 1999, International journal of pharmaceutics.
[77] R. Neufeld,et al. DNA protection from extracapsular nucleases, within chitosan- or poly-L-lysine-coated alginate beads. , 1998, Biotechnology and bioengineering.
[78] D. Attwood,et al. Chitosan and sodium alginate based bioadhesive tablets for intraoral drug delivery. , 1994, Biological & pharmaceutical bulletin.
[79] P. Darcy,et al. The use of isothermal microcalorimetry in the study of changes in crystallinity of spray-dried salbutamol sulphate , 1995 .
[80] Y. Okamoto,et al. Evaluation of chitin and chitosan on open would healing in dogs. , 1995, The Journal of veterinary medical science.
[81] E. Ernst,et al. Randomized, double-blind trial of chitosan for body weight reduction , 1999, European Journal of Clinical Nutrition.
[82] K. Deuchi,et al. Mechanism for the inhibition of fat digestion by chitosan and for the synergistic effect of ascorbate. , 1995, Bioscience, biotechnology, and biochemistry.
[83] T. Maruyama,et al. Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon. , 1996, Journal of pharmaceutical sciences.
[84] Krishnendu Roy,et al. Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy , 1999, Nature Medicine.
[85] L. Block,et al. Chitinosans as tableting excipients for modified release delivery systems. , 1999, International journal of pharmaceutics.
[86] A. Bernkop‐Schnürch,et al. Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[87] G. Mahrous,et al. Preparation and evaluation of sustained release cross-linked chitosan microspheres containing phenobarbitone. , 1998, Journal of microencapsulation.
[88] J. Smart,et al. An in vitro mucosal model predictive of bioadhesive agents in the oral cavity. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[89] S. Davis,et al. Sustained release chitosan microspheres prepared by novel spray drying methods. , 1999, Journal of microencapsulation.
[90] J. Akbuǧa,et al. The effect of the physicochemical properties of a drug on its release from chitosonium malate matrix tablets , 1993 .
[91] Y. Okamoto,et al. Chitin and chitosan stimulate canine polymorphonuclear cells to release leukotriene B4 and prostaglandin E2. , 1998, Journal of biomedical materials research.
[92] M. Ishihara,et al. Photocrosslinkable chitosan as a biological adhesive. , 2000, Journal of biomedical materials research.
[93] Y. Seino,et al. Hypoglycemic and hypolipidemic effect of chitosan in normal and neonatal streptozotocin-induced diabetic mice. , 1995, Biological & pharmaceutical bulletin.
[94] T. Ohno,et al. Controlled release of interleukin-2 for tumour immunotherapy using alginate/chitosan porous microspheres , 1997 .
[95] H. Junginger,et al. Mucoadhesive polymers in peroral peptide drug delivery. IV. Polycarbophil and chitosan are potent enhancers of peptide transport across intestinal mucosae in vitro , 1997 .
[96] J. Schwartz,et al. Microencapsulation of chlorpheniramine maleate-resin particles with crosslinked chitosan for sustained release. , 1999, Pharmaceutical development and technology.
[97] A. Bernkop‐Schnürch. Chitosan and its derivatives: potential excipients for peroral peptide delivery systems. , 2000, International journal of pharmaceutics.
[98] C. Pruzzo,et al. Inhibition of Streptococcus mutans Adsorption to Hydroxyapatite by Low-molecular-weight Chitosans , 1997, Journal of dental research.
[99] J. Akbuğa,et al. Effect of formulation variables on cis-platin loaded chitosan microsphere properties. , 1999, Journal of microencapsulation.
[100] B. Connell,et al. Development of an injectable sustained-release formulation of morphine: antinociceptive properties in rats , 1998, Laboratory animals.
[101] D. Grant,et al. Physical characteristics and release behavior of salbutamol sulfate beads prepared with different ionic polysaccharides. , 1998, Drug development and industrial pharmacy.
[102] K. Sall,et al. The effect of chitosan on corneal wound healing. , 1987, Annals of ophthalmology.
[103] M. Kawai,et al. Rheological properties and fractal structure of concentrated polyion complexes of chitosan and alginate. , 1993, Biorheology.
[104] H. Kaş. Chitosan: properties, preparations and application to microparticulate systems. , 1997, Journal of microencapsulation.
[105] H. Junginger,et al. Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[106] L. Opletal,et al. [Phytotherapeutic aspects of diseases of the circulatory system. 4. Chitin and chitosan]. , 1995, Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti.
[107] M. Takada,et al. Sustained-release and intragastric-floating granules of indomethacin using chitosan in rabbits. , 1988, Chemical & pharmaceutical bulletin.
[108] D. Attwood,et al. Drug release from oral mucosal adhesive tablets of chitosan and sodium alginate , 1995 .
[109] M. Sargon,et al. Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery. , 2000, International journal of pharmaceutics.
[110] Y. Yamamoto,et al. Release characteristics of cisplatin chitosan microspheres and effect of containing chitin. , 1990, Chemical & pharmaceutical bulletin.
[111] G. Smistad,et al. Bioadhesion of hydrated chitosans: An in vitro and in vivo study , 1996 .
[112] P. Cullis,et al. Nomenclature for synthetic gene delivery systems. , 1997, Human gene therapy.
[113] I. Gouda,et al. Heparin-chitosan complexes stimulate wound healing in human skin. , 1997, Scandinavian journal of plastic and reconstructive surgery and hand surgery.
[114] H. Hayatsu,et al. Polynucleotide-chitosan complex, an insoluble but reactive form of polynucleotide. , 1997, Chemical & pharmaceutical bulletin.
[115] F. Bartone,et al. Chitosan: effects on wound healing in urogenital tissue: preliminary report. , 1988, The Journal of urology.
[116] R. Duncan,et al. Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. , 1999, International journal of pharmaceutics.
[117] J. Torres,et al. Chitosan‐Poly(acrylic acid): Mechanism of Complex Formation and Potential Industrial Applications , 1990, Biotechnology progress.
[118] T. Nagai,et al. Use of chitosan for sustained-release preparations of water-soluble drugs. , 1982, Chemical & pharmaceutical bulletin.